Research at the Lymphoma Lab is driven by the observation that the outcomes of lymphoma are extremely variable with some patients seem cured or enjoying long remissions while others experience relapse. Treatments that directly target the underlying therapeutic vulnerabilities of a patient’s lymphoma remain unavailable [1]. Lymphoma Lab wants to change this. A comprehensive understanding […]
Read More